BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

282 related articles for article (PubMed ID: 25707352)

  • 1. Effects of antiviral medications on herpetic epithelial keratitis in mice.
    Komoto S; Higaki S; Fukuda M; Shimomura Y
    Jpn J Ophthalmol; 2015 May; 59(3):194-200. PubMed ID: 25707352
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of oral valaciclovir on herpetic keratitis.
    Higaki S; Itahashi M; Deai T; Fukuda M; Shimomura Y
    Cornea; 2006 Dec; 25(10 Suppl 1):S64-7. PubMed ID: 17001196
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Battle with herpes for 37 years].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2015 Mar; 119(3):145-66; discussion 167. PubMed ID: 25854108
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of anti herpetic drugs on mice with herpetic epithelial keratitis after reactivation of herpes simplex virus type 1.
    Itahashi M; Higaki S; Shimomura Y
    Semin Ophthalmol; 2008; 23(4):241-7. PubMed ID: 18584562
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In vivo antiviral efficacy of a dipeptide acyclovir prodrug, val-val-acyclovir, against HSV-1 epithelial and stromal keratitis in the rabbit eye model.
    Anand BS; Hill JM; Dey S; Maruyama K; Bhattacharjee PS; Myles ME; Nashed YE; Mitra AK
    Invest Ophthalmol Vis Sci; 2003 Jun; 44(6):2529-34. PubMed ID: 12766053
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Herpes simplex virus latency, reactivation, and a new antiviral therapy for herpetic keratitis].
    Shimomura Y
    Nippon Ganka Gakkai Zasshi; 2008 Mar; 112(3):247-64; discussion 265. PubMed ID: 18411713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy of herpes virus helicase-primase inhibitor, ASP2151, for treating herpes simplex keratitis in mouse model.
    Sasaki S; Miyazaki D; Haruki T; Yamamoto Y; Kandori M; Yakura K; Suzuki H; Inoue Y
    Br J Ophthalmol; 2013 Apr; 97(4):498-503. PubMed ID: 23361434
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of famciclovir on herpes simplex virus type 1 corneal disease and establishment of latency in rabbits.
    Loutsch JM; Sainz B; Marquart ME; Zheng X; Kesavan P; Higaki S; Hill JM; Tal-Singer R
    Antimicrob Agents Chemother; 2001 Jul; 45(7):2044-53. PubMed ID: 11408221
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Development of Herpes Simplex Virus Infectious Epithelial Keratitis During Oral Acyclovir Therapy and Response to Topical Antivirals.
    Carter SB; Cohen EJ
    Cornea; 2016 May; 35(5):692-5. PubMed ID: 26989961
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of efficacies of famciclovir and valaciclovir against herpes simplex virus type 1 in a murine immunosuppression model.
    Field HJ; Tewari D; Sutton D; Thackray AM
    Antimicrob Agents Chemother; 1995 May; 39(5):1114-9. PubMed ID: 7625798
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Clinical characteristics of acyclovir-resistant herpetic keratitis and experimental studies of isolates.
    Yao YF; Inoue Y; Kase T; Uchihori Y; Mori Y; Ohashi Y
    Graefes Arch Clin Exp Ophthalmol; 1996 Aug; 234 Suppl 1():S126-32. PubMed ID: 8871163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Famciclovir and valaciclovir differ in the prevention of herpes simplex virus type 1 latency in mice: a quantitative study.
    Thackray AM; Field HJ
    Antimicrob Agents Chemother; 1998 Jul; 42(7):1555-62. PubMed ID: 9660982
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparison of efficacy of oral valacyclovir and topical acyclovir in the treatment of herpes simplex keratitis: a randomized clinical trial.
    Sozen E; Avunduk AM; Akyol N
    Chemotherapy; 2006; 52(1):29-31. PubMed ID: 16340195
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Herpes simplex virus keratitis: an update of the pathogenesis and current treatment with oral and topical antiviral agents.
    Tsatsos M; MacGregor C; Athanasiadis I; Moschos MM; Hossain P; Anderson D
    Clin Exp Ophthalmol; 2016 Dec; 44(9):824-837. PubMed ID: 27273328
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pediatric herpes simplex of the anterior segment: characteristics, treatment, and outcomes.
    Liu S; Pavan-Langston D; Colby KA
    Ophthalmology; 2012 Oct; 119(10):2003-8. PubMed ID: 22796308
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Herpes simplex virus genome quantification in two patients who developed herpetic epithelial keratitis during treatment with antiglaucoma medications.
    Deai T; Fukuda M; Hibino T; Higaki S; Hayashi K; Shimomura Y
    Cornea; 2004 Mar; 23(2):125-8. PubMed ID: 15075880
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antiviral efficacies of famciclovir, valaciclovir, and brivudin in disseminated herpes simplex virus type 1 infection in mice.
    Wutzler P; Ulbricht A; Färber I
    Intervirology; 1997; 40(1):15-21. PubMed ID: 9268766
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Topical treatment with nerve growth factor in an animal model of herpetic keratitis.
    Lambiase A; Coassin M; Costa N; Lauretti P; Micera A; Ghinelli E; Aloe L; Rama P; Bonini S
    Graefes Arch Clin Exp Ophthalmol; 2008 Jan; 246(1):121-7. PubMed ID: 17479276
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Archipelago keratitis: a clinical variant of recurrent herpetic keratitis?
    Gabison EE; Alfonsi N; Doan S; Racine L; Sultan G; Baudouin C; Hoang-Xuan T
    Ophthalmology; 2007 Nov; 114(11):2000-5. PubMed ID: 17418418
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Phenotypic and genotypic characterization of acyclovir-resistant corneal HSV-1 isolates from immunocompetent patients with recurrent herpetic keratitis.
    Burrel S; Boutolleau D; Azar G; Doan S; Deback C; Cochereau I; Agut H; Gabison EE
    J Clin Virol; 2013 Sep; 58(1):321-4. PubMed ID: 23731845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.